Meet the Authors SESSION 2- Promoting Best Practices for Medical Science Liaisons Position Statement from the APPA, IFAPP, MAPS and MSLS

In July, MAPS partnered with APPA Australia , IFAPP Academy and the Medical Science Liaison Society to produce a joint position paper on the role of Medical Science Liaisons in the pharmaceutical industry. September 1st, we hosted a discussion with some of the paper authors to discuss consensus on best practices.

In part two of that first discussion, you’ll hear from more of the authors on:

  • What is an MSL or Field Medical?
  • How are these roles different from traditional field roles?
  • What does the future look like?
  • How did COVID change things?
  • What gaps remain for these roles?
  • How really do we measure outcomes at a patient level?
Moderator: Robin Winter-Sperry, MD

Moderator: Robin Winter-Sperry, MD

MAPS Director and Membership Committee Chair, Global MSL Lead, Ipsen
Speaker: Donna Holder, PharmD

Speaker: Donna Holder, PharmD

Senior Director, Global MSL Excellence Oncology, Daiichi Sankyo
Speaker: Ralph Rewers, PharmD

Speaker: Ralph Rewers, PharmD

Senior Director, Head Global MSL Excellence – Onco, AstraZeneca
Speaker: Matthew Britland

Speaker: Matthew Britland

Medical Director, Amgen, V.P of APPA
Read the Full Position Statement Here

Watch Webinar:


Watch Interview with Robin Winter-Sperry & Matthew Britland:

Connect with Us

602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073

© 2025 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.

Subscribe to MAPS Newsletter
MAPS Program Support Services
Policies and Positions
Early Career Professionals: Paths Into Medical AffairsEarly Career Professionals: Paths Into Medical AffairsPatient Education to Boost Clinical Trial Understanding and Enrollment: A Case...